Angel Invest Boston

Invest Alongside Boston's Top Angels: Our Syndicates Scientist and intrapreneur Gillian Isabelle, PhD, founded Enlivity (https://enlivity.com/) to make chemotherapy more bearable for cancer patients. The first product is a supplement invented by an oncologist that helps prevent sores from forming in the mouths and digestive tracts of patients receiving chemotherapy, a problem that can delay life-saving treatment. A fun interview with an infectiously affable guest. Gillian Isabelle studied material science at UC Berkeley and received her PhD from MIT. Worked at Corning and then at PureTech Health, the remarkable promising new pharma company started in Boston. At the Broad Institute she set up and ran the business development office to bring is licensing revenue from the Broad’s research. Gillian Isabelle is the founder of Enlivity, a startup dedicated to improving the lives of patients receiving chemotherapy. Radiation and chemotherapy have serious side effects that include sores in the mouth and the digestiv